Drugs / BAY85-8050
last change Dec 2009 re-read 3 minutes ago

BAY85-8050

Investigated by
Bayer

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00961831 Apr → Dec 2009 neoplasm Bayer Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BAY 85-8050 “the [F18] Labeled PET (Positron Emission Tomography) Tracer BAY 85-8050 Following a Single Intravenous Administration” NCT00961831 ↗
1

NCT00961831 ↗

Route Intravenous “single intravenous administration” NCT00961831 ↗